A
statement from
the Royal Society for Biology, in relation to the United Nations
agreeing to take action on antimicrobial resistance
“The
Learned Society Partnership on Antimicrobial Resistance (LeSPAR) welcomes news
of global political and pharmaceutical industry support for actions to tackle
the threat of resistant infections.
The
G7 and G20 summits and the UN General Assembly have now agreed proactive steps
to ensure collaboration between nations, accepting the recommendations of the
WHO Global Action Plan on AMR and the UK AMR Review. In particular they have
agreed:
Support
for all countries to design and implement national action plans
Initiatives
to stimulate research and development of new antimicrobial products
Public
awareness and engagement activities
In
line with these agreements, the pharmaceutical industry has published a roadmap
with an emphasis on public-private partnership. This guides both the
development of new drugs and the management of access to antimicrobials, where
and when they are needed.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources